← Back
Data updated: Mar 29, 2026
ENCUBE
DermatologyOncologyImmunology
Generics
ENCUBE is a generic drug manufacturer focused on Dermatology, Oncology, Immunology.
2003
Since
36
Drugs
-
Trials
350
Approved (2yr)
Key Drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Dermatology 43%
6 drugs
Oncology 29%
4 drugs
Immunology 14%
2 drugs
Gastroenterology 7%
1 drugs
Cardiovascular 7%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Pfizer big-pharma
Oncology, Dermatology, Immunology, Gastroenterology
BAUSCH specialty
Dermatology, Immunology, Cardiovascular, Gastroenterology
COSETTE other
Cardiovascular, Dermatology, Immunology, Oncology
Novartis big-pharma
Oncology, Cardiovascular, Immunology
Merck big-pharma
Oncology, Cardiovascular, Immunology
Active (22)
TRETINOIN MICROSPHERE TAVABOROLE HALCINONIDE ADAPALENE AND BENZOYL PEROXIDE CLINDAMYCIN PHOSPHATE AND TRETINOIN IMIQUIMOD CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE TACROLIMUS MESALAMINE FLUTICASONE PROPIONATE MUPIROCIN KETOCONAZOLE CICLOPIROX ESTRADIOL DICLOFENAC SODIUM CLINDAMYCIN PHOSPHATE BETAMETHASONE DIPROPIONATE NITROGLYCERIN DAPSONE FLUOCINONIDE ERYTHROMYCIN FLUOROURACIL
Discontinued (12)
Company Info
- First Approval
- 2003-08-27
- Latest
- 2026-02-10
- Applications
- 59